Strong public policy strategies help MedTech companies influence regulations, shape market entry, and build trust with governments and institutions. We provide expert guidance in policy research, advocacy, and stakeholder engagement to help you stay ahead of regulatory changes and position your business for long-term success.
We provide in-depth analysis of India’s healthcare and MedTech ecosystem, identifying opportunities, market size, competitive landscape, and reimbursement frameworks. Our research spans across:
India’s fragmented healthcare delivery often creates demand-supply mismatches across product categories. We analyze distribution inefficiencies, regional availability of devices, patient access trends, and diagnostic infrastructure. This helps companies:
Our assessments are particularly useful for devices like surgical dressings, IVD kits, diagnostic imaging, and therapeutic wearables.
We help define the optimal India entry strategy—whether greenfield, brownfield, or partnership-based. This includes:
For companies seeking to establish a legal presence in India, we facilitate:
We ensure legal setup aligns with future CDSCO licensing and operational needs.
For companies planning to manufacture or assemble in India under Make-in-India or PLI schemes, we provide:
This enables clients to operationalize a compliant facility within accelerated timelines.
India’s distribution landscape can be opaque and highly localized. We help identify, vet, and engage reliable:
We facilitate negotiations and onboarding with performance metrics and compliance support.
Beyond entry, we provide retained support for:
Local HR recruitment and vendor identification
This ensures sustainable operations post-launch without compromising compliance or growth.
We offer M&A advisory services for companies looking to:
Our support spans legal due diligence, IP valuation, cultural fit analysis, and post-merger integration guidance—all within the Indian regulatory and business environment.
Connect with us